What is the appropriate prescription regimen for acute gouty arthritis?

Prescription for Acute Gouty Arthritis

For acute gouty arthritis, prescribe one of the following first-line anti-inflammatory agents: NSAIDs (e.g., indomethacin 50 mg three times daily or naproxen 500 mg twice daily), colchicine 1.2 mg followed by 0.6 mg one hour later (then 0.6 mg once or twice daily), or corticosteroids (e.g., prednisone 30-40 mg daily for 5-7 days with taper). 1

Acute Flare Management

The 2020 ACR guidelines strongly recommend initiating anti-inflammatory prophylaxis therapy when treating acute gout 1. The choice between NSAIDs, colchicine, or corticosteroids should be based on patient-specific factors:

NSAIDs

• Preferred if: No contraindications (renal disease, cardiovascular disease, gastrointestinal bleeding risk)
• Dosing: Maximum recommended doses for short duration
• Evidence: Moderate-quality evidence shows NSAIDs and COX-2 inhibitors produce similar pain reduction (1.9 points on 0-10 scale), though COX-2 inhibitors have fewer adverse events (38% vs 60% total adverse events) 2
• Common regimens: Indomethacin 50 mg TID, naproxen 500 mg BID, or COX-2 selective agents

Colchicine

• Preferred if: NSAIDs contraindicated or in combination therapy
• Dosing: Low-dose regimen (1.2 mg loading dose, then 0.6 mg one hour later) has comparable efficacy to high-dose with significantly better tolerability 3
• Maintenance: 0.6 mg once or twice daily
• Caution: Reduce dose in renal impairment

Corticosteroids

• Preferred if: NSAIDs and colchicine contraindicated or polyarticular involvement
• Dosing: Prednisone 30-40 mg daily for 5-7 days, then taper
• Evidence: Moderate-quality evidence shows equivalent pain reduction to NSAIDs (9.5 points on 0-100 scale, MD 1.74 higher with NSAIDs, not statistically significant) 2
• Routes: Oral, intramuscular, or intra-articular depending on presentation

Long-Term Management Considerations

If this is a recurrent attack or the patient has indications for urate-lowering therapy (ULT), the ACR guidelines conditionally recommend starting ULT during the acute flare rather than waiting for resolution 1. When initiating ULT:

Prophylaxis Protocol

• Strongly recommended: Continue anti-inflammatory prophylaxis for 3-6 months (not <3 months) 1
• Options: Colchicine 0.6 mg daily or twice daily, low-dose NSAIDs, or low-dose prednisone (≤10 mg daily)
• Rationale: Prevents flares during ULT initiation

Urate-Lowering Therapy

• First-line agent: Allopurinol starting at ≤100 mg/day (lower in CKD stage ≥3), titrate to target 1
• Target: Serum uric acid <6 mg/dL (<360 μmol/L)
• Alternative: Febuxostat starting at ≤40 mg/day if allopurinol contraindicated

Critical Pitfalls to Avoid

• Do not use opioids: Despite 28% of ED patients receiving opioids for acute gout, this practice should be avoided given effective alternatives and the opioid epidemic 4
• Do not start ULT at high doses: Low starting doses with gradual titration reduce flare risk 1
• Do not use high-dose colchicine: Low-dose regimen equally effective with better tolerability 3
• Do not skip prophylaxis: When initiating ULT, prophylaxis is strongly recommended to prevent paradoxical flares 1

Patient-Specific Modifications

Renal impairment (CKD stage ≥3):

• Reduce colchicine dose
• Avoid NSAIDs
• Prefer corticosteroids
• Start allopurinol at ≤50 mg/day

Polyarticular involvement:

• Consider systemic corticosteroids over NSAIDs
• Higher risk of fever (CRP and pain scores are independent risk factors) 5

Cardiovascular disease:

• Avoid NSAIDs
• Prefer colchicine or corticosteroids